Total Payments
$1,709
2024 Payments
$26.58
Companies
20
Transactions
95
Medicare Patients
966
Medicare Billing
$64,855
Payment Breakdown by Category
Food & Beverage$1,610 (94.2%)
Education$99.99 (5.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,610 | 94 | 94.2% |
| Education | $99.99 | 1 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $317.91 | 14 | $0 (2020) |
| Novo Nordisk Inc | $272.61 | 19 | $0 (2020) |
| Merz North America, Inc. | $249.51 | 1 | $0 (2023) |
| Allergan, Inc. | $215.24 | 21 | $0 (2020) |
| Astellas Pharma US Inc | $104.84 | 2 | $0 (2017) |
| Amarin Pharma Inc. | $104.10 | 6 | $0 (2021) |
| PFIZER INC. | $70.08 | 5 | $0 (2021) |
| AbbVie Inc. | $54.98 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50.79 | 4 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $48.46 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.58 | 1 | REVANCE THERAPEUTICS, INC. ($26.58) |
| 2023 | $249.51 | 1 | Merz North America, Inc. ($249.51) |
| 2021 | $127.10 | 9 | AbbVie Inc. ($54.98) |
| 2020 | $323.87 | 31 | Allergan, Inc. ($117.47) |
| 2019 | $29.43 | 2 | Novo Nordisk Inc ($15.94) |
| 2018 | $251.09 | 17 | AstraZeneca Pharmaceuticals LP ($118.74) |
| 2017 | $701.91 | 34 | Novo Nordisk Inc ($201.89) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/16/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/26/2023 | Merz North America, Inc. | Xeomin (Biological) | Food and Beverage | In-kind items and services | $249.51 | General |
| Category: Dermatology | ||||||
| 05/28/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular | ||||||
| 05/26/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: NEUROSCIENCE | ||||||
| 05/17/2021 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Neurology | ||||||
| 05/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Cardiovascular | ||||||
| 04/28/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Diabetes | ||||||
| 04/15/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/22/2020 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 11/23/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/06/2020 | PFIZER INC. | FLECTOR (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/05/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 164 | 192 | $108,648 | $11,282 |
| 2020 | 16 | 802 | 1,002 | $163,133 | $53,573 |
Total Patients
966
Total Services
1,194
Medicare Billing
$64,855
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 60 | $41,480 | $3,792 | 9.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 24 | 24 | $25,472 | $3,636 | 14.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 53 | $24,362 | $2,148 | 8.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 37 | $17,080 | $1,653 | 9.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 16 | 18 | $254.00 | $54.00 | 21.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 126 | 126 | $41,202 | $16,701 | 40.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 172 | 272 | $38,896 | $9,352 | 24.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 125 | 186 | $39,432 | $8,623 | 21.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 69 | 71 | $4,260 | $4,229 | 99.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 14 | 14 | $6,356 | $3,057 | 48.1% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 11 | 11 | $2,387 | $2,360 | 98.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 12 | $3,876 | $2,039 | 52.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 70 | 84 | $7,392 | $1,749 | 23.7% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 13 | 13 | $1,885 | $1,519 | 80.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 74 | 76 | $8,740 | $1,446 | 16.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 15 | 15 | $4,230 | $1,119 | 26.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 15 | $780.00 | $511.13 | 65.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 23 | 24 | $2,232 | $453.78 | 20.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 16 | 17 | $833.00 | $205.61 | 24.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 29 | 40 | $320.00 | $119.40 | 37.3% |
| 81002 | Urinalysis, manual test | Office | 2020 | 19 | 26 | $312.00 | $89.57 | 28.7% |
About Dr. Arthur Miller, MD
Dr. Arthur Miller, MD is a Family Medicine healthcare provider based in Highland Park, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033287164.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arthur Miller, MD has received a total of $1,709 in payments from pharmaceutical and medical device companies, with $26.58 received in 2024. These payments were reported across 95 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,610).
As a Medicare-enrolled provider, Miller has provided services to 966 Medicare beneficiaries, totaling 1,194 services with total Medicare billing of $64,855. Data is available for 2 years (2020–2021), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Highland Park, NJ
- Active Since 11/30/2006
- Last Updated 03/13/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1033287164
Products in Payments
- Xeomin (Biological) $249.51
- BEVESPI AEROSPHERE (Drug) $163.54
- FARXIGA (Drug) $154.37
- Victoza (Drug) $144.74
- UBRELVY (Drug) $129.48
- Vascepa (Drug) $104.10
- Levemir (Drug) $67.99
- Ozempic (Drug) $59.88
- BYSTOLIC (Drug) $53.67
- JANUVIA (Drug) $48.46
- VIBERZI (Drug) $44.10
- VRAYLAR (Drug) $42.97
- TRULICITY (Drug) $28.98
- DAXXIFY (Drug) $26.58
- Trintellix (Drug) $19.87
- COLOGUARD DNA CAPTURE REAGENTS (Device) $15.00
- BOOSTRIX (Biological) $14.81
- MENACTRA (Drug) $14.81
- APLENZIN (Drug) $14.27
- PREVNAR 13 (Biological) $14.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Highland Park
Dr. Ruth Mays, Md, MD
Family Medicine — Payments: $3,743
Family Medicine $3,743
Inna Hoffman, Apn, APN
Family Medicine — Payments: $1,500
Family Medicine $1,500
Frederic Glatter, Md, MD
Family Medicine — Payments: $810.13
Family Medicine $810.13
Branden Staller
Family Medicine — Payments: $442.61
Family Medicine $442.61
Dr. Veena Korah, M.d, M.D
Family Medicine — Payments: $421.96
Family Medicine $421.96
Dr. Sunitha Nambiar, M.d, M.D
Family Medicine — Payments: $212.61
Family Medicine $212.61